Two Chinese anti-SARS-CoV-2 drugs conditionally approved for marketing
Two Chinese oral anti-SARS-CoV-2 drugs, Xiannuoxin (simnotrelvir/ritonavir) and VV116 (deuremidevir hydrobromide), were conditionally approved for marketing by China's National Medical Products Administration (NMPA) in late ...
10 hours ago
0
18